Clinical and radiological characteristics of 17 Chinese patients with pathology confirmed tumefactive demyelinating diseases: Follow-up study
Jiarui Yao(Hong Kong Baptist University), WU Wei-ping(Chinese PLA General Hospital), Dehui Huang(Chinese People's Liberation Army), Jie Li(Nanjing University of Chinese Medicine), Xiaolei Chen(Shanghai Institute of Geological Survey), Lei Wu, Xin Lou(Chinese General Hospital College of Nursing and Liberal Arts), Qiuping Gui(Capital Medical University), Cheng Chen(Dalian Medical University)
Cited by 11
Related Papers
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2021|708
Tumor Susceptibility of <i>Rassf1a</i> Knockout Mice
|Cancer Research|2005|214
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study
|The Lancet Oncology|2020|193
Pro-inflammatory and proliferative microglia drive progression of glioblastoma
|Cell Reports|2021|165